Analyst Ratings for Akari Therapeutics (AKTX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/5/2022 | H.C. Wainwright | Sean Lee | New Coverage | Buy (N/A) |
1.50 (N/A) |
0.54 (1.21) |
124.07% | Details |
| 11/1/2022 | Alliance Global Partners | James Malloy | New Coverage | Buy (N/A) |
N/A (N/A) |
0.47 (1.21) |
157.45% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
